Compounds / Other / Cystagen

Cystagen

Cystagen (Lys-Glu dipeptide — bladder bioregulator)
OtherFDA: Not approved — not evaluated by FDA

Overview

Derived from Prostatilen peptide research. Russian studies report improved bladder function and reduced inflammation in chronic cystitis and age-related bladder dysfunction.

Mechanism of Action

Khavinson bioregulatory dipeptide targeting bladder/urinary tract. Proposed to modulate urothelial gene expression for tissue repair and anti-inflammatory response.

Molecular Profile

Molecular weight
275.3 Da

Key Research Findings

Bladder-targeting Khavinson peptide; anti-inflammatory; derived from Prostatilen research.

Published Research

Advances in Gerontology
Peptide bioregulators: a new class of geroprotectors
View source
Rejuvenation Research
Molecular aspects of peptide regulation of aging
View source

Related Other Compounds

PT-141Melanotan IMelanotan IIPNC-27DermorphinEPO
Clinical Guidance

Research data is not a treatment plan. If you are considering Cystagen, the questions that matter are whether it suits your history, your labs and your goals. That is a conversation with a licensed physician, not a lookup.

Speak with a physician LATOM Wellness is a physician-led telehealth practice. Consultation only. No compound is sold on this site.
Running Cystagen? Log doses and track your cycle.

Interactive tools for this compound:

Reconstitution calculator  ·  Full deep dive  ·  Peptide fundamentals